Page 2 of 507
, Pharmacology Illustrated Reviews7th Edition Whalen TestBank yi yi yi yi yi yi yi
yi TABLE OF CONTENT yi yi
Chapter 1: Pharmacokinetics
y i y i
Chapter 2: Drug–Receptor Interactions and Pharmacodynamics
yi yi yi yi yi
y Chapter 3: The Autonomic Nervous System
i yi y i y i yi yi
Chapter 4: Cholinergic Agonists
yi yi yi
Chapter 5: Cholinergic Antagonists
yi yi yi yi
Chapter 6: Adrenergic Agonists
yi yi yi yi
Chapter 7: Adrenergic Antagonists
yi yi yi yi
Chapter 8: Drugs for Neurodegenerative Diseases
yi yi yi yi yi
Chapter 9: Anxiolytic and Hypnotic Drugs
yi yi yi yi yi yi
Chapter 10: Antidepressants
yi yi
Chapter 11: Antipsychotic Drugs
yi yi yi yi
Chapter 12: Drugs for Epilepsy
yi yi yi yi yi
Chapter 13: Anesthetics
yi yi yi
Chapter 14: Opioids
y i y i
Chapter 15: Drugs of Abuse
yi yi yi yi
Chapter 16: CNS Stimulants
yi yi yi yi
Chapter 17: Antihypertensives
yi yi yi
Chapter 18: Diuretics
yi yi yi
Chapter 19: Heart Failure
y i y i y i
Chapter 20: Antiarrhythmics
yi yi
Chapter 21: Antianginal Drugs
yi yi yi yi
Chapter 22: Anticoagulants and Antiplatelet Agents
yi yi yi yi yi
Chapter 23: Drugs for Hyperlipidemia
y i yi yi yi yi
Chapter 24: Pituitary and Thyroid
yi yi yi yi
Chapter 25: Drugs for Diabetes
yi yi yi yi yi
Chapter 26: Estrogens and Androgens
yi yi yi yi
Chapter 27: Adrenal Hormones
yi yi yi yi
Chapter 28: Drugs for Obesity
yi y i y i yi
Chapter 29: Drugs for Disorders of the Respiratory System
yi yi yi yi yi yi yi yi
Chapter 30: Antihistamines
y i yi yi
Chapter 31: Gastrointestinal and Antiemetic Drugs
yi yi yi yi yi
Chapter 32: Drugs for Urologic Disorders
yi yi yi yi yi y i
Chapter 33: Drugs for Anemia
yi y i y i yi
Chapter 34: Drugs for Dermatologic Disorders
yi yi yi yi yi
Chapter 35: Drugs for Bone Disorders
yi yi yi yi yi yi
Chapter 36: Anti-inflammatory, Antipyretic, and Analgesic Agents
yi yi yi yi y i yi
Chapter 37: Principles of Antimicrobial Therapy
y i yi y i yi y i y i
Chapter 38: Cell Wall Inhibitors
yi y i yi y i
Chapter 39: Protein Synthesis Inhibitors
y i y i y i y i
Chapter 40: Quinolones, Folic Acid Antagonists, and Urinary Tract Antiseptics
yi yi yi yi y i y i y i y i yi
Chapter 41: Antimycobacterial Drugs
yi yi yi yi
Chapter 42: Antifungal Drugs
yi yi yi
Chapter 43: Antiprotozoal Drugs
yi yi yi yi
Chapter 44: Anthelmintic Drugs
yi yi yi yi
Chapter 45: Antiviral Drugs
yi yi yi yi
Chapter 46: Anticancer Drugs
y i y i y i
Chapter 47: Immunosuppressants
yi yi
Chapter 48: Clinical Toxicology
yi yi yi yi
Page 3 of 507
,Page 4 of 507
, 3. The nurse is teaching a patient who will be discharged home with a prescription for an enteric-
coated tablet. Which statement by the patient indicates understanding of the teaching?
a. I may crush the tablet and put it in applesauce to improve absorption.
b. I should consume acidic foods to enhance absorption of this medication.
c. I should expect a delay in onset of the drugs effects after taking the tablet.
d. I should take this medication with high-fat foods to improve its action.
ANS: C
Enteric-coated tablets resist disintegration in the acidic environment of the stomach and
disintegrate when they reach the small intestine. There is usually some delay in onset of actions
after taking these medications. Enteric-coated tablets should not be crushed or chewed, which
would alter the time and location of absorption. Acidic foods will not enhance the absorption of
the medication. The patient should not to eat high-fat food before ingesting an enteric-coated
tablet, because high-fat foods decrease the absorption rate.
DIF: COGNITIVE LEVEL: Applying (Application) REF: dm 3
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
4. A patient who is newly diagnosed with type 1 diabetes mellitus asks why insulin must be
given by subcutaneous injection instead of by mouth. The nurse will explain that this is because
a. absorption is diminished by the first-pass effects in the liver.
b. absorption is faster when insulin is given subcutaneously.
c. digestive enzymes in the gastrointestinal tract prevent absorption.
d. the oral form is less predictable with more adverse effects.
ANS: C
Insulin, growth hormones, and other protein-based drugs are destroyed in the small intestine by
digestive enzymes and must be given parenterally. Because insulin is destroyed by digestive
enzymes, it would not make it to the liver for metabolism with a first-pass effect. Subcutaneous
Page 5 of 507
, Pharmacology Illustrated Reviews7th Edition Whalen TestBank yi yi yi yi yi yi yi
yi TABLE OF CONTENT yi yi
Chapter 1: Pharmacokinetics
y i y i
Chapter 2: Drug–Receptor Interactions and Pharmacodynamics
yi yi yi yi yi
y Chapter 3: The Autonomic Nervous System
i yi y i y i yi yi
Chapter 4: Cholinergic Agonists
yi yi yi
Chapter 5: Cholinergic Antagonists
yi yi yi yi
Chapter 6: Adrenergic Agonists
yi yi yi yi
Chapter 7: Adrenergic Antagonists
yi yi yi yi
Chapter 8: Drugs for Neurodegenerative Diseases
yi yi yi yi yi
Chapter 9: Anxiolytic and Hypnotic Drugs
yi yi yi yi yi yi
Chapter 10: Antidepressants
yi yi
Chapter 11: Antipsychotic Drugs
yi yi yi yi
Chapter 12: Drugs for Epilepsy
yi yi yi yi yi
Chapter 13: Anesthetics
yi yi yi
Chapter 14: Opioids
y i y i
Chapter 15: Drugs of Abuse
yi yi yi yi
Chapter 16: CNS Stimulants
yi yi yi yi
Chapter 17: Antihypertensives
yi yi yi
Chapter 18: Diuretics
yi yi yi
Chapter 19: Heart Failure
y i y i y i
Chapter 20: Antiarrhythmics
yi yi
Chapter 21: Antianginal Drugs
yi yi yi yi
Chapter 22: Anticoagulants and Antiplatelet Agents
yi yi yi yi yi
Chapter 23: Drugs for Hyperlipidemia
y i yi yi yi yi
Chapter 24: Pituitary and Thyroid
yi yi yi yi
Chapter 25: Drugs for Diabetes
yi yi yi yi yi
Chapter 26: Estrogens and Androgens
yi yi yi yi
Chapter 27: Adrenal Hormones
yi yi yi yi
Chapter 28: Drugs for Obesity
yi y i y i yi
Chapter 29: Drugs for Disorders of the Respiratory System
yi yi yi yi yi yi yi yi
Chapter 30: Antihistamines
y i yi yi
Chapter 31: Gastrointestinal and Antiemetic Drugs
yi yi yi yi yi
Chapter 32: Drugs for Urologic Disorders
yi yi yi yi yi y i
Chapter 33: Drugs for Anemia
yi y i y i yi
Chapter 34: Drugs for Dermatologic Disorders
yi yi yi yi yi
Chapter 35: Drugs for Bone Disorders
yi yi yi yi yi yi
Chapter 36: Anti-inflammatory, Antipyretic, and Analgesic Agents
yi yi yi yi y i yi
Chapter 37: Principles of Antimicrobial Therapy
y i yi y i yi y i y i
Chapter 38: Cell Wall Inhibitors
yi y i yi y i
Chapter 39: Protein Synthesis Inhibitors
y i y i y i y i
Chapter 40: Quinolones, Folic Acid Antagonists, and Urinary Tract Antiseptics
yi yi yi yi y i y i y i y i yi
Chapter 41: Antimycobacterial Drugs
yi yi yi yi
Chapter 42: Antifungal Drugs
yi yi yi
Chapter 43: Antiprotozoal Drugs
yi yi yi yi
Chapter 44: Anthelmintic Drugs
yi yi yi yi
Chapter 45: Antiviral Drugs
yi yi yi yi
Chapter 46: Anticancer Drugs
y i y i y i
Chapter 47: Immunosuppressants
yi yi
Chapter 48: Clinical Toxicology
yi yi yi yi
Page 3 of 507
,Page 4 of 507
, 3. The nurse is teaching a patient who will be discharged home with a prescription for an enteric-
coated tablet. Which statement by the patient indicates understanding of the teaching?
a. I may crush the tablet and put it in applesauce to improve absorption.
b. I should consume acidic foods to enhance absorption of this medication.
c. I should expect a delay in onset of the drugs effects after taking the tablet.
d. I should take this medication with high-fat foods to improve its action.
ANS: C
Enteric-coated tablets resist disintegration in the acidic environment of the stomach and
disintegrate when they reach the small intestine. There is usually some delay in onset of actions
after taking these medications. Enteric-coated tablets should not be crushed or chewed, which
would alter the time and location of absorption. Acidic foods will not enhance the absorption of
the medication. The patient should not to eat high-fat food before ingesting an enteric-coated
tablet, because high-fat foods decrease the absorption rate.
DIF: COGNITIVE LEVEL: Applying (Application) REF: dm 3
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
4. A patient who is newly diagnosed with type 1 diabetes mellitus asks why insulin must be
given by subcutaneous injection instead of by mouth. The nurse will explain that this is because
a. absorption is diminished by the first-pass effects in the liver.
b. absorption is faster when insulin is given subcutaneously.
c. digestive enzymes in the gastrointestinal tract prevent absorption.
d. the oral form is less predictable with more adverse effects.
ANS: C
Insulin, growth hormones, and other protein-based drugs are destroyed in the small intestine by
digestive enzymes and must be given parenterally. Because insulin is destroyed by digestive
enzymes, it would not make it to the liver for metabolism with a first-pass effect. Subcutaneous
Page 5 of 507
